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ABSTRACT:  For this study the essential oil (EO) of sage (Salvia officinalis L.) was 1
isolated from air-dried vegetative aerial parts of the plants by hydrodistillation and 2
analysed by GC and GC-MS. A total yield of 12.07 mg of EO per g of plant dry mass 3
was obtained and more than 50 compounds identified. The major compounds were cis-4
thujone (17.4 %), -humulene (13.3 %), 1,8-cineole (12.7 %), E-caryophyllene (8.5 %) 5
and borneol (8.3 %). The EO fraction of sage tea was also isolated by partition with 6
pentane and the respective components identified. The toxic and antioxidant protective 7
effects of S. officinalis EO were evaluated on freshly isolated rat hepatocytes. Cell 8
viability (LDH leakage), lipid peroxidation and glutathione status were measured in 9
experiments undertaken with cells (suspensions of 1×106 cells per millilitre) exposed to 10
EO alone (toxicity of the EO; t-BHP as positive control); and with cells exposed to EO 11
and an oxidative compound (t-BHP) together (in EO protection evaluation; quercetin as 12
positive control) for 30 min. The results show that the EO is not toxic when present at 13
concentrations below 200 nl/ml; it was only at 2000 nl EO/ml that a significant LDH 14
leakage and GSH decrease were observed indicating cell damage. In the range of 15




















Sage (Salvia officinalis L.) enjoys the reputation of being a panacea because of 27
its wide range of medicinal effects: it has been used as an antihydrotic, spasmolytic, 28
antiseptic and  anti-inflammatory and in the treatment of mental and nervous conditions 29
(Baricevic and Bartol, 2000). Sage is also used traditionally in food preparation. 30
Recently several authors reported the antioxidant properties of sage and some of 31
its constituents, mainly phenolic compounds such as carnosic, rosmarinic, caffeic and 32
salvianolic acids as well as other phenolic structure-based compounds (Cuvelier et al., 33
1994; Hohmann et al., 1999; Lu and Foo, 2001; Wang et al., 1998; Zupko et al., 2001). 34
Sage is, therefore, one of the favourite candidate species as a source of natural 35
antioxidants in health care products. The essentaial oils (EOs) of some other plants have 36
also been shown to have antioxidant and hepatoprotective activities (Cuppett and Hall, 37
1998; Teissedre and Waterhouse, 2000), although the potentially hepatoprotective 38
effects of sage EO have, to our knowledge, not been investigated. However, potentially 39
toxic effects of sage EO especially to the liver – the main detoxifying organ – may also 40
exist and place limitations on the use of sage.  41
Sage EO is a complex mixture of tens of volatile compounds including 42
monoterpenes, sesquiterpenes and diterpenes. Importantly, the EO contributes the 43
unique flavour of sage and justifies the use of sage as a food condiment. Although some 44
data already exist relating to the toxicity or antioxidant properties of some individual 45
compounds (such as thujone and eugenol, respectively) (Cuppett and Hall, 1998; Millet 46
et al., 1981), to assess the effects of the complex mixture of EO as it reaches the 47
consumer remains the best way to predict and prevent possible deleterious effects of its 48
use.  49
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The present study aims to evaluate the toxic versus antioxidant protective 50
activities of the essential oil from S. officinalis on freshly isolated rat hepatocytes. As 51
specific objectives the experiments had in view (a) to test whether the use of the S.52
officinalis EO of known composition has any adverse effects on the liver, and (b) test 53 
for any antioxidant effects of sage EO on liver cells challenged with an oxidizing agent 54
(tert-butyl hydroperoxide – t-BHP) and compare it to the effects of the reference 55
antioxidant quercetin. 56
57 
MATERIALS AND METHODOS 58
Chemicals. All reagents were of analytical grade. The following reagents were 59
obtained from Sigma (St. Louis, MO, USA): collagenase (grade IV), tert-butyl 60
hydroperoxide (t-BHP), bovine serum albumin, HEPES (N-[2-61
Hydroxyethyl]piperazine-N’-[2-ethane-sulfonic acid]), reduced glutathione (GSH), 62
oxidised glutathione (GSSG), glutathione reductase (EC 1.6.4.2.), 5,5’-dithio-bis-(2-63
nitrobenzoic acid) (DTNB), L-nicotinamide adenine dinucleotide phosphate reduced 64
form (L-NADPH), L-nicotinamide adenine dinucleotide reduced form (L-NADH), 65
quercetin and 2-thiobarbituric acid (TBA). 66
Plant material and isolation of the essential oil. The essential oil used in this 67
study was obtained by hydrodistillation of 226 g of air-dried vegetative aerial parts of S.68
officinalis plants cultivated in an experimental farm located in Arouca, Portugal, and 69
collected on April, 2001. The absolute quantification of each compound was tentatively 70
achieved by GC using 5-cholestane as an internal standard. For this purpose, 71
subsamples of 10 g from the same plant material were submitted to hydrodistillation in 72
a Clevenger type apparatus over 1 h, using volumes of 1.0 mL of n-hexane, containing 73
5-cholestane (1mg/mL), for retention of the hydrodistillate components. 74
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Preparation of sage tea and isolation of the essential oil constituents. 75
Considering that sage is traditionally used as a tea, an infusion of sage was prepared by 76
pouring 150 ml of boiling water onto 2 g of the same dried plant material and allowing 77
to steep for 5 min. The essential oil constituents of the tea were extracted, at room 78
temperature, with 5 mL of n-pentane containing 5-cholestane (1mg/mL). 79
Analysis conditions of essential oils and procedures. The samples of the 80
essential oils and essential oil constituents from tea containing the internal standard 5-81
cholestane were analyzed by GC and GC-MS. GC analyses were performed using a 82
Perkin-Elmer Autosystem gas chromatograph equipped with a fused silica DB5 column 83
(30 m long ×0.25 mm i.d., 0.25 µm film thickness composed by 5 % phenyl 84
methylpolysiloxane, J & W Scientific). Injections were performed in a split/spliless 85
injector with the splitter opened at the 1:13 split ratio under a column head pressure of 86
12.5 psi and H2 as carrier gas at a flow rate of 1.49 ml/min. Oven temperature was 87
programmed from 60 to 285 ºC at 3 ºC min-1. Injector and detector temperatures were 88
300 and 320 ºC, respectively. The same column and conditions were used in the 89
analysis performed with the GC-MS with the exception of the carrier gas which was 90
helium instead of H2. The GC-MS consisted of a Perkin-Elmer 8500 gas chromatograph 91
equipped with a fused silica DB5 column, the same as that for GC, connected to a 92
Finnigan MAT ion trap detector (ITD; software version 4.1) operating in EI mode at 70 93
eV. Identification of the chromatogram peaks as well as quantification of the 94
compounds was performed following the methodology previously described (Santos-95
Gomes and Fernandes-Ferreira, 2001). 96
Animals. Adult male Wistar rats, weighing 200-250 g, were used as hepatocyte 97
donors. The rats were kept in polyethylene cages lined with wood shavings, with wire 98
mesh top and acclimated to ambient temperature (20 ± 2 ºC) and humidity and natural 99
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light/dark cycle. The animals had free access to standard rat chow and tap drinking 100
water, and were kept in our facilities for at least 2 weeks prior to use.  101
Hepatocyte isolation and incubation. Hepatocyte isolation was performed 102
between  10.00 am and 11.00 am by collagenase perfusion of the liver as previously 103
described (Moldeus et al., 1978) with some modifications. In brief, the liver was 104
perfused in situ via the portal vein with a calcium-free Hank’s  solution with 0.67 % 105
albumin and 12.5 mM HEPES (pH 7.4) at 37 ºC at a flow rate of 10 ml/min, then with a 106
Hank’s solution with 12.5 mM HEPES containing 0.025 % collagenase and 0.44 % 107
(w/v) CaCl2 at the same flow rate and temperature for 10 min. The cells were dispersed 108
in Ca2+-free Hank’s solution with 0.67% albumin and 12.5 mM HEPES and washed by 109
low speed centrifugation (50 ×g) for 2 min. The cells were then ressuspended in Krebs-110
Henseleit solution with 12.5 mM HEPES and washed two more times. The hepatocytes 111
viability was > 80% as estimated by trypan blue exclusion. 112
Incubations were performed at 37ºC in suspensions of 106 viable cells per 113
milliliter in Krebs-Henseleit solution with 12.5 mM HEPES (pH 7.4) gassed with 114
carbogen (95 % O2 and 5 % CO2). The hepatocytes were always preincubated for 60 115
min at 37ºC before the beginning of the experiments. Both toxic and protective effects 116
of S. officinalis EO were tested on hepatocyte suspensions. In toxicity experiments the 117
cells were incubated with 10 µl/ml of EO dissolved in DMSO at final concentrations of 118
0, 2, 20, 200 and 2000 nl/ml cell suspension for 30 min. tert-Butyl hydroperoxide (t-119
BHP) 0.75 mM was used as a positive control for cell damage. In hepatoprotective 120
experiments 10 µl/ml of EO dissolved in DMSO at final concentrations of 0, 2, 20, 200 121
and 2000 nl/ml were added to the cell suspensions 5 min before the addition of t-BHP 122
0.75 mM and allowed to incubate simultaneously for 30 minutes. The reference 123
antioxidant quercetin was used as positive control in the protective experiments. The 124
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cells were incubated with 10 µl/ml of quercetin dissolved in DMSO at final 125
concentrations of 0, 1.6, 12.5, 50 and 200 µM for 5 min before addition of t-BHP 0.75 126
mM for 30 min. At the end of experiments, aliquots of cell suspensions were taken for 127
measurement of lactate dehydrogenase (LDH) leakage, malondialdehyde, GSH and 128
GSSG contents. 129
Analytical procedures. Cell death was estimated by quantification of LDH 130
activity in the incubation medium versus total LDH activity in the samples (the results 131
are shown as percentages of control cell viability). The enzyme activity was measured at 132
room temperature by quantification of NADH by continuous spectrophotometry (at 340 133
nm) on a plate reader (Spectra Max 340pc, Molecular Devices). 134
The extent of lipid peroxidation was determined indirectly by the 135
malondialdehyde formation after the breakdown of polyunsaturated fatty acids, 136
measured by the thiobarbituric acid reactive substances (TBARS) assay at 535 nm as 137
described previously (Fernandes et al., 1995). 138
The glutathione content of cell suspensions was determined by the DTNB-GSSG 139
reductase recycling assay as described in Anderson (1985), with some modifications. 140
Briefly, 200 µl of cell suspension was added to 200 µl of 10 % (w/v) 5-sulfosalicylic 141
acid for protein precipitation and centrifuged 2 min at 12000 rpm. Supernatant aliquots 142
were taken out for measurement of total glutathione (GSx) following the DTNB 143
oxidation at 415 nm and compared with a standard curve. The final concentrations of 144
the assay reagents were 0.6 mM DTNB, 0.21 mM NADPH and 2 U/ml glutathione 145
reductase. For the GSSG determination, 100 µl of supernatant was derivatized with 2 µl146
of 2- vinylpyridine and 10 µl of 50 % (v/v) ethanolamide and mixed continuously for 60 147
min. GSSG was then measured as described above for total glutathione. The GSH 148
content was calculated by subtracting GSSG content from the total glutathione content. 149
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Statistical analysis. Data are expressed as means ± SEM (n=5) (cells obtained 150
from 5 different rats). Significant differences between control and t-BHP treated cells 151
were determined by Student’s t-test. Significant differences within EO series (EO toxic 152
and protective evaluation) were determined by one-way ANOVA followed by Dunnett’s 153
test. Differences were considered significant when PT0.05.154
155 
RESULTS 156
Essential oil and essential oil constituents of tea from S. officinalis leaves. The yield 157
of the essential oil obtained by hydrodistillation of air-dried sage aerial parts was 13.3 158
µl per gram of biomass dry weight, corresponding to 1.2% (w/w). The composition of 159
the S. officinalis EO used in the experiments here reported is shown in Table 1, where 160
compounds are listed according to their Kovats retention indexes. The EO includes 161
around 60 compounds most of which were identified (Santos-Gomes and Fernandes-162
Ferreira, 2001). Around 88% of the compounds can be distributed into three terpene 163
groups: oxygen-containing monoterpenes (47.7%), sesquiterpene hydrocarbons 164
(24.5%), and monoterpene hydrocarbons (15.9%). The major compounds were cis-165
thujone (17.4 %), -humulene (13.3 %), 1,8-cineole (12.7 %), E-caryophyllene (8.5 %) 166
and borneol (8.3 %). 167
In the preparation of the tea only 2.99 % of total essential oil content was 168
extracted from the biomass and found in the water giving a final concentration of 4.81 169
µg of EO per ml of tea (Table 1). However, the presence of the individual essential oil 170
constituents in tea was not proportional to their specific amount in the oil extracted by 171
hydrodistillation. From the approximate 60 compounds detected in the essential oil of S.172
officinalis only 25 were found as essential oil constituents of the respective tea (Table 173
1). Oxygen-containing monoterpenes corresponded to 86% of the tea essential oil 174
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constituents. The sum of cis-thujone and camphor concentrations (1.68 and 0.51 µg.ml-175 
1, respectively) corresponded to almost 45% of all the constituents (Table 1). With 176
respect to the composition of EO present in tea it is not surprising that oxygen-177
containing monoterpenes, such as cis-thujone and camphor, are proportionately more 178
abundant in tea than other EO constituents in view of the higher solubility in water of 179
this group of compounds relatively to the other ones.  180
Surprisingly, the values of the specific contents of the alkanes n-undecane, n-181
hexacosane and n-octacosane determined in the tea were higher than the corresponding 182
values determined in the essential oil (Table 1) obtained by hydrodistillation. The 183
respective loss during hydrodistillation is a possibility that can not be ruled out. 184
EO toxicity experiments. EO toxicity was tested in hepatocyte suspensions 185
exposed to the EO (0-2000 nl/ml) and compared to that of t-BHP (0.75 mM). Cell 186
viability measured by LDH leakage of rat hepatocytes (fig. 1) did not change 187
significantly after 30 min incubation with 0 – 200 nl of EO per ml of cell suspension. 188
However, 2000 nl/ml (0.2 % (v/v)) caused a significant decrease in cell viability. Lipid 189
peroxidation (Table 2) did not change after the incubations with different concentrations 190
of EO. Total glutathione (GSx) (Table 2) was significantly lowered by incubation with 191
the highest oil concentration tested (2000 nl/ml) but not by any of the other 192
concentrations. This decrease in GSx was accompanied by a decrease in GSH (fig. 2), 193
where incubations with 200 nl EO/ml also produced a significant decrease in GSH when 194
compared to the control. There were no significant changes in GSSG content (Table 2) 195
produced by incubation of the cells with the EO. 196
The incubations of hepatocyte suspensions with the positive control 0.75 mM t-197
BHP for 30 min resulted in significant decreases in cell viability (fig. 1), GSH (fig. 2) as 198
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well as GSx content and an increase in lipid peroxidation (Table 2). We also observed a 199
perceptible increase of GSSG content (P = 0.0556) with this toxicant. 200
EO protection experiments. Hepatoprotection of the EO was tested in 201
hepatocyte suspensions exposed simultaneously to the EO (0-2000 nl/ml) and t-BHP 202
(0.75 mM) and the protective effects of the oil compared to those of quercetin. 203
The addition of 0.75 mM t-BHP to hepatocytes resulted in significant cell death 204
after 30 min was evident from LDH leakage (fig 3). EO in the concentrations of 2-2000 205
nl/ml did not reduce cell mortality. Quercetin, on the other hand, significantly reduced 206
LDH leakage at 200 µM. Lipid peroxidation induced by t-BHP (Table 4) was also 207
significantly reduced by co-incubation with quercetin whereas the EO had no protective 208
effects at any of the concentrations tested (Table 3). Addition of t-BHP significantly 209
reduced cell GSH content but no protective effects on the glutathione balance could be 210
detected for quercetin or the EO (fig 4). Co-incubation of t-BHP with 2000 nl/ml EO 211
seems to further decrease the GSH levels in the cells. 212
213 
DISCUSSION 214
The liver is very active in metabolizing foreign compounds. The 215
biotransformation of xenobiotics by the liver involves chemical modifications that 216
globally increase their water solubility thereby facilitating their elimination from the 217
organism in bile and urine.  These reactions may, however, result in the formation of 218
compounds of greater toxicity. Although the large biotransforming ability of the liver 219
allows efficient elimination of the most toxic compounds, it also makes hepatocytes a 220
vulnerable target for toxic effects. Damage to the cell’s constituents such as lipid 221
peroxidation may occur. Reduced GSH plays an important role in hepatocytes defence 222
(Kedderis, 1996; Reed, 1990). The most common pathway of glutathione depletion in 223
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xenobiotic toxicity is excessive consumption of GSH without recovery (Castell et al., 224
1997). Severe GSH depletion leaves cells more vulnerable to oxidative damage which 225
causes progressive deterioration of macromolecules, cell structure and may lead to cell 226
death. GSH level could therefore determine the cytotoxicity of a xenobiotic and its 227
ultimate effects on cell survival. 228
Our data shows that sage EO was not toxic to rat hepatocyte suspensions when 229
present in concentrations below 200 nl/ml for 30 min; it was only at 2000 nl of EO per 230
ml of hepatocyte suspension that a significant LDH leakage and GSH decrease occurred 231
indicating cell damage. cis-Thujone,  the major constituent of sage EO (17.4%, see 232
Table1), has been shown to be neurotoxic and implicated in the effects of absinth 233
consumption (Hold et al., 2000; Hold et al., 2001). Results by Bonkovsky and co-234
workers (Bonkovsky et al., 1992) and our own preliminary data (not shown) indicates 235
that cis-thujone in concentrations below 1 mM (960 nl EO/ml) does not decrease 236
hepatocyte viability and seem therefore not to be toxic to the liver. Judging by thujone 237
toxicity alone we would not expected toxicity to the liver of EO concentrations below 238
200 nl/ml. However, a decrease in hepatocyte GSH was apparent at this EO 239
concentration indicating some degree of toxicity. This emphasises the need for the 240
evaluation of the toxicity of the actual EO – a mixture of compounds – since the toxicity 241
of the mixture can not in all cases be inferred from the toxicity of its individual 242
compounds. 243
The toxicity induced by t-BHP is well-known and is well characterized 244
(Fernandes et al., 1995; Joyeux et al., 1990; Tseng et al., 1997) and our results are in 245
agreement with these published reports. Our data also show that when compared with t-246
BHP-induced toxicity, which is the result of GSx and GSH depletion, GSSG increase 247
and lipid peroxidation, cell death induced by the EO at 2000 nl/ml on liver cells does 248
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not seem to be mediated by lipid peroxidation and GSH oxidation with concomitant 249
GSSG increase. The EO toxicity may be due to the presence of reactive compounds 250
and/or reactive metabolites generated by metabolism of EO. The depleted glutathione 251
was possibly recruited to act as a nucleophilic scavenger of some compounds and/or 252
their metabolites with electrophilic properties. The cellular death indicated by LDH 253
leakage could also be due to a solvent effect of the essential oil, whereby the  254
hydrophobic compounds exert a direct effect on cellular membranes disturbing the 255
physico-chemical properties of the bilayer culminating in the disruption of cellular 256
volume and cell death (Berry et al., 1991; Kedderis, 1996). 257
The hepatoprotective effects of the EO were tested by co-incubation with the 258
toxicant t-BHP and compared with those of the reference antioxidant quercetin. 259
Quercetin shows concentration-dependent protective effects against t-BHP-induced 260
toxicity in almost all parameters measured. Quercetin was preferred to other known 261
antioxidants as a positive control because of its plant origin, DMSO solubility and for 262
having a well characterised protective effect against t-BHP-induced toxicity (Joyeux et 263
al., 1990). In contrast, the presence of sage EO did not reduce hepatocyte death due to t-264
BHP toxicity. The co-incubation with the EO resulted in a tendency for a further 265
decrease in GSH and increased lipid peroxidation.  In spite of the reputation of some 266
plant EOs as antioxidants and hepatoprotectants in animal models (Teissedre and 267
Waterhouse, 2000 and references therein), our results do not show antioxidant 268
protective effects of S. officinalis EO against t-BHP-induced liver toxicity. 269
The EO obtained by hydrodistillation used in this study was somewhat lower 270
than that obtained from fresh leaves of the same sage cultivar (Santos-Gomes and 271
Fernandes-Ferreira, 2001). The composition of sage EO extracts varies and reflects 272
extraction conditions as well as time of harvest and the plant’s growth conditions such 273
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as climate, soil composition and light intensity (Santos-Gomes and Fernandes-Ferreira, 274
2001). In April, the composition of the essential oil from S. officinalis plants grown in 275
Portugal (Santos-Gomes and Fernandes-Ferreira, 2001) and in Israel (Putievsky et al., 276
1986) are characterised by the lowest levels of cis-thujone and camphor. The levels of 277
these two compounds in the EO used (Table 1), were slightly lower than the 278
corresponding minimum values from the profile defined by the standard ISO 9909 279
(1999) for the essential oil of S. officinalis - cis-thujone (18-43%), camphor (4.5-24.5%) 280
(Bruneton, 1999). It is therefore important that detailed information is available on the 281
material being tested or used in the food industry. 282
In summary, our results indicate that the hepatoprotective properties attributed to 283
S. officinalis seem not to be due to the essential oil fraction. At doses higher than 200 284
nl/ml acting directly on the liver the EO may cause toxicity. The neurotoxicity of 285
thujones and camphor, major compounds of S. officinalis EO, as well as hepatotoxicity 286
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Table 1. Composition of the essential oil and essential oil constituents of tea prepared 
from vegetative aerial parts of S. officinalis L. plants collected in April, before anthesis. 
Compound 
 Essential oil from 
Salvia officinalis 
Essential oil constituents from 
Salvia officinalis tea 
RIa % µg/g dry wt % µg/g dry wt µg/ml of tea 
1-Butyl acetate 813 trb 2.1 - - - 
cis-2-Methyl-3-methylene-hep-5-ene 847 0.7 68.1 - - - 
trans-2-Methyl-3-methylene-hep-5-ene 857 0.1 7.6 2.1 5.2 0.069 
Tricyclene 920 0.1 11.3 - - - 
-Thujene 924 0.1 8.9 - - -
-Pinene 930 4.1 399.1 tr 0.3 0.005 
Camphene 946 3.1 298.4 tr 0.4 0.006 
Sabinene 970 0.1 6.3 - - - 
-Pinene 974 4.5 437.0 tr 0.5 0.007 
Myrcene 988 0.5 48.0 - - - 
n-Decane 1000 tr 1.3 - - - 
-Phellandrene 1004 0.1 5.5 - - -
-Terpinene 1016 0.2 18.9 - - -
p-Cymene 1022 0.1 13.7 - - - 
Limonene 1024 1.5 142.4 - - - 
1,8-Cineole 1033 12.7 1703.9 18.1 66.3 0.884 
Z--Ocimene 1034 0.3 26.5 - - -
E--Ocimene 1044 0.4 39.2 - - -
-Terpinene 1055 0.1 4.4 - - -
cis-Linalool oxide 1072 0.1 6.7 - - - 
Terpinolene 1086 0.2 15.7 - - - 
n-Undecane 1100 tr 0.8 1.1 2.7 0.036 
Linalool 1101 tr tr  - - -
cis-Thujone [= (-)-thujone] 1103 17.4 2491.4 34.0 125.9 1.678 
trans-Thujone [=(+)-thujone 1114 3.9 518.5 5.3 20.1 0.268 
-Campholenal 1125 0.1 13.5 - - -
Not identified 1129 0.2 29.9 tr 0.9 0.013 
Camphor 1143 3.3 445.4 10.6 38.4 0.512 
cis-Pinocamphone [= (cis-3-)-Pinanone] 1160 0.7 97.8 1.1 4.3 0.057 
Borneol 1165 8.3 1109.5 13.8 52.3 0.697 
Pinocamphone isomer (T) 1172 0.2 30.3 1.1 2.0 0.027 
4-Terpineol 1176 0.2 25.6 tr 1.2 0.016 
-Terpineol 1189 0.3 32.7 - - -
Not identified 1201 0.3 43.0 2.1 9.2 0.123 
Bornyl acetate 1283 0.9 127.9 tr 1.3 0.017 
cis-Sabinyl acetate 1290 0.1 9.8 - - - 
Not identified 1322 0.3 47.2 - - - 
Not identified 1328 0.1 11.3 - - - 
-Elemene 1334 0.1 8.8 - - -
trans-Carvyl acetate 1337 tr 0.5 - - - 
cis-Carvyl acetate 1362 0.1 18.5 - - - 
Neryl acetate 1364 0.3 38.8 - - - 
-Bourbonene + Geranyl acetate 1383+1384 0.1 10.8 - - -
-Caryophyllene 1416 8.5 836.9 tr 1.0 0.014 
Aromadendrene or -Guaiene (?) 1436 0.8 82.2 - - -
-Humulene 1450 13.3 1305.7 1.1 1.6 0.022 
allo-Aromadendrene 1458 0.1 13.2 - - - 
Germacrene D isomer #3 1473 0.5 46.5 - - - 
Germacrene D 1477 0.1 4.6 - - - 
-Selinene 1491 0.5 49.4 1.1 2.0 0.026 
-Cadinene 1520 0.6 62.9 - - -
Caryophyllene oxide 1580 0.5 65.9 1.1 3.2 0.043 
Viridiflorol 1595 6.2 834.0 tr 1.4 0.019 
Widdrol (?) 1606 0.7 96.4 - - - 
Z--trans-Bergamatol acetate 1801 0.1 8.9 - - -
Not identified 1903 tr 4.1 1.1 2.4 0.032 
Manool 2063 2.4 248.7 1.1 1.8 0.024 
n-Hexacosane 2600 tr 1.1 3.2 9.9 0.132 
n-Octacosane 2800 tr 2.6 2.1 6.5 0.087 
Grouped components  
Monoterpene hydrocarbons  15.9 1553.8 2.1 6.5 0.086 
Oxygen-containing monoterpenes  47.7 6565.5 86.2 320.6 4.274 
Monoterpenyl esters  1.8 243.7 0.0 1.3 0.017 
Sesquiterpene hydrocarbons  24.5 2410.2 2.1 4.6 0.062 
Oxygen-containing sesquiterpenes  7.4 996.4 1.1 4.6 0.062 
Sesquiterpenyl esters  tr 8.9 - - - 
Oxygen-containing diterpenes  2.4 248.7 1.1 1.8 0.024 
Others  0.3 38.3 7.4 21.5 0.286 
Total  100.0  12065.4 100.0 360.8 4.810 
a Kovats retention index relatively to n-alkanes in a DB-5 column.  b tr, trace amounts (< 0.05) 
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Table 2. Effect of 30 min exposure of hepatocyte suspensions to S. officinalis essential 
oil on GSSG and GSx content and on lipid peroxidation expressed as TBARS formation 
(means ± SEM). n=5; # PT0.05 between control and t-BHP treated cells; * PT0.05 when 
compared with control cells. 
 
Sample 
t-BHP EO (nl/ml) Parameter 
(0.75 mM) 0 (contr) 2 20 200 2000 
TBARS 
(nmol/million cells) 1.99 ± 0.16 
# 0.94 ± 0.12 0.89 ± 0.11 0.87 ± 0.09 0.79 ± 0.14 0.89 ± 0.12 
GSx content 
(nmol/million cells) 35.2 ± 1.7 
# 45.1 ± 3.5 43.9 ± 4.2 43.4 ± 3.2 39.7 ± 4.1 28.4 ± 3.3 *
GSSG content 
(nmol/million cells) 13.1 ± 1.6 9.2 ± 0.9 9.5 ± 0.8 9.8 ± 0.9 10.1 ± 1.7 10.2 ± 2.0 
Table 3. Anti-hepatotoxic effect of S. officinalis essential oil on hepatocyte suspensions 
damaged by t-BHP (0.75 mM) for 30 min, on GSSG and GSx content and on lipid 
peroxidation expressed as TBARS formation (means ± SEM). n=5; # PT0.05 between 
control and cells treated only with t-BHP. 
 
Sample 
t-BHP (0.75 mM) + EO (nl/ml) series Parameter (-) control 0 2 20 200 2000
TBARS 
(nmol/million cells) 0.92 ± 0.09 2.08 ± 0.13 
# 2.14 ± 0.23 2.20 ± 0.20 2.22 ± 0.30 2.88 ± 0.59 
GSx content 
(nmol/million cells) 44.6 ± 4.9 35.9 ± 2.2 31.1 ± 3.0 33.4 ± 2.6 29.4 ± 2.6 22.5 ± 3.3 
GSSG content 
(nmol/million cells) 10.5 ± 1.1 13.5 ± 1.9 12.7 ± 2.1 12.6 ± 1.8 11.7 ± 1.8 10.6 ± 1.8 
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Table 4. Anti-hepatotoxic effect of quercetin (positive control) on hepatocyte 
suspensions damaged by t-BHP (0.75 mM) for 30 min, on GSSG and GSx content and 
on lipid peroxidation expressed as TBARS formation (means ± SEM). n=5; # PT0.05 
between control and cells treated only with t-BHP; * PT0.05 when compared with cells 
treated only with t-BHP. 
 
Sample 
t-BHP (0.75 mM) + quercetin (µM) series Parameter (-) control 0 1.6 12.5 50 200
TBARS 
(nmol/million cells) 0.92 ± 0.09 2.08 ± 0.13 
# 2.09 ± 0.24 1.35 ± 0.15* 0.72 ± 0.04* 0.79 ± 0.10* 
GSx content 
(nmol/million cells) 44.6 ± 4.9 35.9 ± 2.2 37.7 ± 1.9 37.0 ± 1.8 35.2 ± 1.0 31.9 ± 3.2 
GSSG content 
(nmol/million cells) 10.5 ± 1.1 13.5 ± 1.9 13.8 ± 1.9 12.7 ± 2.1 11.2 ± 1.8 8.7 ± 1.2 
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Figure 1. Effect of essential oil of S. officinalis on 
cell viability (measured by % of LDH leakage) in 
hepatocyte suspensions after 30 min of exposure 
(means ± SEM). n=5; # PT0.05 between control 
and t-BHP treated cells; * PT0.05 when compared 
with control cells.  
Figure 2. Effect of essential oil of S. officinalis on 
hepatocyte suspensions GSH content after 30 min 
of exposure (means ± SEM). n=5; # PT0.05 
between control and t-BHP treated cells; * PT0.05 
when compared with control cells. 
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t-BHP(0.75mM) + protectant series
Figure 3. Effect of essential oil of S. officinalis
and quercetin (insert) on cell viability (measured 
by % of LDH leakage) of hepatocyte suspensions
damaged by t-BHP (0.75 mM) for 30 min 
(means ± SEM). n=5; # PT0.05 between control 
and cells treated only with t-BHP; * PT0.05
when compared with cells treated only with t-
BHP. 
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t-BHP(0.75mM) + protectant series
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Figure 4. Effect of essential oil of S. officinalis
and quercetin (insert) on GSH content of 
hepatocyte suspensions damaged by t-BHP (0.75 
mM) for 30 min (means ± SEM). n=5; # PT0.05 
between control and cells treated only with t-
BHP. 
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